Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study.

NCT02137954 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Pain With Neuropathic Component

Interventions

DRUG: Lidocaine
DRUG: Placebo

Sponsor

Assistance Publique Hopitaux De Marseille